About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Our research group is accredited by the Agency for Management of University and Research Grants (AGAUR) in Catalonia, and focuses on two main areas of interest which are related to Solid Organ Transplantation and especially Kidney, and in clinical Nephrology. We tackle these areas from an innovative perspective, both basic-experimental and mechanistic, always with a translational goal. On the one hand, we investigate, develop, and use novel diagnostic and therapeutic technologies to decipher and target main molecular and immune mechanisms of transplant rejection as well as the immune susceptibility to opportunistic infections and malignancies. Also, a main task force of the group is devoted to better understand the main mechanisms involved in certain autoimmune glomerular diseases and idiopathic nephrotic syndrome as well as in diabetic kidney disease, having a specific interest in the role of the renin-angiotensin system. Our ultimate goal is to improve the management and care of patients suffering from kidney diseases as well as their quality of life, reducing associated morbidity and mortality.
PMID: 35806939 Journal: Journal of Clinical Medicine Year: 2022 Reference: J Clin Med. 2022 Jun 24;11(13). pii: jcm11133651. doi: 10.3390/jcm11133651. Impact factor: 4.242 Publication type: Letter or abstract Authors: Gomez Preciado, Francisco; De Carvalho Ovalles, Rosa Alejandra; Codina, Sergi; Donadeu, Laura; Fava, Alexandre; Martinez Valenzuela, Laura; Sandoval, Diego; Fernandez-Cidon, Barbara; Bestard, Oriol; Alia-Ramos, Pedro et al. DOI: 10.3390/jcm11133651
PMID: 35833145 Journal: Frontiers in Immunology Year: 2022 Reference: Front Immunol. 2022 Jun 27;13:869554. doi: 10.3389/fimmu.2022.869554. eCollection 2022. Impact factor: 7.561 Publication type: Paper in international publication Authors: Crespo, Elena, Vidal-Alabro, Anna, Jouve, Thomas, Fontova, Pere, Stein, Maik, Mocka, Sonila, Meneghini, Maria, Sefrin, Anett, Hruba, Petra, Goma, Montserrat et al. DOI: 10.3389/fimmu.2022.869554
PMID: 35817409 Journal: SEMINARS IN DIALYSIS Year: 2022 Reference: Semin Dial. 2022 Jul 11. doi: 10.1111/sdi.13114. Impact factor: 3.455 Publication type: Paper in international publication Authors: Toapanta, Nestor, Comas, Jordi, Leon Roman, Juan, Ramos, Natalia, Azancot, Maria, Bestard, Oriol, Tort, Jaume, Soler, Maria Jose et al. DOI: 10.1111/sdi.13114
PMID: 35669973 Journal: TRANSPLANT INTERNATIONAL Year: 2022 Reference: Transpl Int. 2022 May 20;35:10140. doi: 10.3389/ti.2022.10140. eCollection 2022. Impact factor: 3.782 Publication type: Editorail in international publication Authors: Roufosse, Candice, Becker, Jan Ulrich, Rabant, Marion, Seron, Daniel, Bellini, Maria Irene, Bohmig, Georg A, Budde, Klemens, Diekmann, Fritz, Glotz, Denis, Naesens, Maarten et al. DOI: 10.3389/ti.2022.10140
PMID: 34217504 Journal: NEFROLOGIA Year: 2021 Reference: Nefrologia (Engl Ed). 2021 May 27. pii: S0211-6995(21)00105-3. doi: 10.1016/j.nefro.2021.04.004. Impact factor: 2.033 Publication type: Letter or abstract Authors: Toapanta, Nestor, Castaneda, Zaira, Zuniga, Jose, Leon-Roman, Juan, Ramos, Natalia, Azancot, Maria, Soler, Maria Jose et al. DOI: 10.1016/j.nefro.2021.04.004
PMID: 34221392 Journal: Clinical Kidney Journal Year: 2021 Reference: Clin Kidney J. 2021 Mar 15;14(7):1848-1850. doi: 10.1093/ckj/sfab058. eCollection 2021 Jul. Impact factor: 4.452 Publication type: Letter or abstract Authors: Segarra Medrano, Alfons, Roig Carcel, Jordi, Estaran, Elena, Abo Rivera, Annabel, Carrera Munoz, Claudia, Gonzalez Rodriguez, Jorge et al. DOI: 10.1093/ckj/sfab058
PMID: 34221369 Journal: Clinical Kidney Journal Year: 2021 Reference: Clin Kidney J. 2020 Feb 10;14(5):1364-1370. doi: 10.1093/ckj/sfaa008. eCollection 2021 May. Impact factor: 4.452 Publication type: Paper in international publication Authors: Oleas, Diana, Bolufer, Monica, Agraz, Irene, Felip, Enriqueta, Munoz, Eva, Gabaldon, Alejandra, Bury, Roxana, Espinel, Eugenia, Seron, Daniel, Garcia-Carro, Clara et al. DOI: 10.1093/ckj/sfaa008
PMID: 34198818 Journal: Journal of Clinical Medicine Year: 2021 Reference: J Clin Med. 2021 Jun 5;10(11). pii: jcm10112505. doi: 10.3390/jcm10112505. Impact factor: 4.242 Publication type: Review in international publication Authors: Bermejo, Sheila, Garcia-Carro, Clara, Vergara, Ander, Sanchez de la Nieta, M Dolores, Agraz, Irene, Soler, Maria Jose, Sanchez-Fructuoso, Ana I, Azancot, Maria A et al. DOI: 10.3390/jcm10112505
The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.
Hypertension, a key risk factor for heart disease that contributes significantly to cardiovascular mortality and morbidity and damage to vital organs, was the focus of this multi-centre study.
The new findings were presented at the American Society of Nephrology's Kidney Week 2024 meeting in San Diego and simultaneously published in the prestigious journal Nature Medicine.
